Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Susanna V. Ulahannan et al.|Journal of Hepatology|2016Cited by 817
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Lisa M. Cordes et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312